Phase 2 Autism Spectrum Disorder Trial, Recruiting (NCT07304440)

Phase 2 Autism Spectrum Disorder Trial, Recruiting NCT07304440 Sponsor: Adia Med of Winter Park LLC Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07304440 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child must be between 3 and 12 years old
The child must have a confirmed diagnosis of Autism Spectrum Disorder (ASD), verified using standard diagnostic tools
The parent or guardian must be willing to consider experimental treatments and follow all study rules and requirements
The family must be able to attend all scheduled appointments throughout the study
The family must be able to pay a study fee of $12,000, plus any additional costs for blood tests if required (confirm with trial site)

Who may not be able to join:

The child has serious allergies to any of the products used in the study
The child has significant medical conditions that are not well controlled
The participant is pregnant or breastfeeding, if applicable
The child has taken part in another clinical trial within the last 30 days
The child has previously received stem cell therapy (including treatments using umbilical cord blood stem cells or exosomes) or glutathione therapy (given by injection or applied to the skin) at any point before joining this study

⚠️ Please note: This trial requires a significant out-of-pocket payment of $12,000 plus potential additional costs. Please make sure you fully understand all financial requirements before proceeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 3217880850

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07304440

Sponsor: Adia Med of Winter Park LLC

Phase: Phase 2

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 3217880850

More information: https://clinicaltrials.gov/study/NCT07304440

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child must be between 3 and 12 years old
The child must have a confirmed diagnosis of Autism Spectrum Disorder (ASD), verified using standard diagnostic tools
The parent or guardian must be willing to consider experimental treatments and follow all study rules and requirements
The family must be able to attend all scheduled appointments throughout the study
The family must be able to pay a study fee of $12,000, plus any additional costs for blood tests if required (confirm with trial site)

Who may not be able to join:

The child has serious allergies to any of the products used in the study
The child has significant medical conditions that are not well controlled
The participant is pregnant or breastfeeding, if applicable
The child has taken part in another clinical trial within the last 30 days
The child has previously received stem cell therapy (including treatments using umbilical cord blood stem cells or exosomes) or glutathione therapy (given by injection or applied to the skin) at any point before joining this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Adia Med of Winter Park LLC

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

15 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline in Total Autism Treatment Evaluation Checklist (ATEC) Score at Month 6

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov